Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The enzyme PST is found in developing human kidneys and helps with detoxification and development.

COVID-19 may harm male fertility and damage the reproductive system.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

ACBP is essential for healthy skin and fur by maintaining the skin's barrier function.

Niosomes are a promising and effective way to deliver drugs through the skin.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Young women with PCOS without additional risk factors may have normal heart function.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

A new drug delivery system using oil body-bound oleosin-rhFGF-10 improves wound healing and hair growth in mice.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.